Full Event Guide
Agenda Highlights Include:
- Examining the mechanisms underlying immune tolerance to drive antigen and epitope discovery with insights from the NIH, Vaccibody and Imcyse
- Leveraging immune biomarkers and explore immune tolerance in diabetes with Novo Nordisk, COUR Pharmaceuticals and Diamyd Medical
- Exploring the diversity of technologies and platforms for antigen delivery with Toleranzia, Allero Therapeutics, Idogen AB and AnTolRx Inc
- Optimizing clinical durability and efficacy of antigen-specific immunotherapies with insights from WORG Pharmaceuticals and Cellerys